Andrew Webb

No open positions remaining

Net worth: 944 329 $ as of 29/06/2026

64 year

Health Technology

Process Industries

Finance

Profile

Mr. Andrew J.
Webb is an Executive Chairman & Chief Executive Officer at CRISM Therapeutics Corp.
and a Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd. He is on the Board of Directors at Novel Technologies Holdings Ltd. and Extruded Pharmaceuticals Ltd. Mr. Webb was previously employed as a Commercial Director by DxS Ltd., a Non-Executive Director by Arcis Biotechnology Ltd., and a Chief Executive Officer by EKF Molecular Diagnostics Ltd. He also served on the board at Convert2Green Ltd.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
9.22%	30/12/2025	7,297,190 ( 9.22% )	944 329 $	29/06/2026

Andrew Webb active positions

Companies	Position	Start
Novel Technologies Holdings Ltd. Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Director/Board Member	22/11/2017

All active positions of Andrew Webb

Former positions of Andrew Webb

Companies	Position	End
DxS Ltd. DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products	Corporate Officer/Principal	-
EKF Molecular Diagnostics Ltd.	Chief Executive Officer	-
Arcis Biotechnology Ltd. Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology	Director/Board Member	-
Convert2Green Ltd. Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution	Director/Board Member	-

See the detail of Andrew Webb's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies